- Keybanc raised the price target for Intuit Inc. INTU from $450 to $475. Keybanc analyst Josh Beck maintained an Overweight rating. Intuit shares fell 1.8% to close at $419.33 on Tuesday.
- Tigress Financial raised the price target for Airbnb, Inc. ABNB from $160 to $185. Tigress Financial analyst Ivan Feinseth reiterated a Buy rating. Airbnb shares fell 1.1% to close at $116.61 on Tuesday.
- Stifel increased the price target for Lululemon Athletica Inc. LULU from $450 to $460. Stifel analyst Jim Duffy maintained a Buy rating. Lululemon shares rose 14.4% to $366.55 in pre-market trading.
- B of A Securities boosted McCormick & Company, Incorporated MKC price target from $73 to $75. B of A Securities analyst Peter Galbo maintained an Underperform rating. McCormick shares gained 9.6% to close at $81.18 on Tuesday.
- Mizuho increased Intra-Cellular Therapies, Inc. ITCI price target from $66 to $74. Mizuho analyst Graig Suvannavejh maintained a Buy rating. Intra-Cellular Therapies shares fell 3% to $54.06 in pre-market trading.
- Oppenheimer raised the price target for Progress Software Corporation PRGS from $53 to $63. Oppenheimer analyst Ittai Kidron maintained an Outperform rating. Progress Software shares fell 1.7% to $57.64 in pre-market trading.
- Guggenheim boosted McDonald's Corporation MCD price target from $302 to $305. Guggenheim analyst Gregory Francfort maintained a Buy rating. McDonald's shares rose 0.7% to close at $275.85 on Tuesday.
- Telsey Advisory Group boosted PVH Corp. PVH price target from $90 to $102. Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating. PVH shares gained 0.2% to $88.51 in pre-market trading.
- Barclays cut nCino, Inc. NCNO price target from $35 to $26. Barclays analyst Saket Kalia maintained an Equal-Weight rating. nCino shares rose 0.1% to close at $22.36 on Tuesday.
- Citigroup raised Domino's Pizza, Inc. DPZ price target from $316 to $328. Citigroup analyst Jon Tower maintained a Neutral rating. Domino's shares rose 0.5% to $325.70 in pre-market trading.
- BTIG raised Viking Therapeutics, Inc. VKTX price target $20 to $31. BTIG analyst Justin Zelin maintained a Buy rating. Viking Therapeutics shares rose 2.9% to $15.88 in pre-market trading.
Check This Out: Check Out 3 High-Yielding Dividend Stocks In Industrials Sector From Wall Street's Most Accurate Analysts
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in